In the context of comprehensively advancing the Healthy China initiative,the high-quality development of public hospitals must be guided by the core principle of"people's health".It provides a systematic analysis of the historical evolution of developmental paradigms in Chinese public hospitals.By integrating the current policy requirements for their high-quality development,it proposes key pathways including the innovation of development concepts,the reconstruction of hospital connotations,the extension of service management,the optimization of the system structure,and the empowerment of digital and intelligent technologies.Through empirical case studies that demonstrate the viability of these pathways,it aims to provide theoretical support and practical reference for the high-quality development of public hospitals centered on people's health.

Amidst the emerging wave of technological revolution and industrial transformation,hospitals urgently need to realize self-reform through"wisdom upgrading"and explore new development paths.The new quality productivity forces shows a high de-gree of suitability in this reform,which opens up a new direction for the innovation of smart hospitals.Through a three-dimensional perspective of"laborers-labor materials-labor objects",smart hospital change and innovation is facing with the dilemma of weak awareness and insufficient ability of workers,insufficient use of labor materials,and limited potential of labor objects to lead the innovation of smart hospitals.Based on these findings,the following implementation pathways are proposed:utilizing principles as the guide to form cultural productivity,employing talent as the impetus to establish knowledge productivity,placing technology at the core to foster integration productivity,recognizing data as key to developing innovative productivity,and using cooperation as the link to create collaborative productivity within smart hospitals.

Amidst the emerging wave of technological revolution and industrial transformation,hospitals urgently need to realize self-reform through"wisdom upgrading"and explore new development paths.The new quality productivity forces shows a high de-gree of suitability in this reform,which opens up a new direction for the innovation of smart hospitals.Through a three-dimensional perspective of"laborers-labor materials-labor objects",smart hospital change and innovation is facing with the dilemma of weak awareness and insufficient ability of workers,insufficient use of labor materials,and limited potential of labor objects to lead the innovation of smart hospitals.Based on these findings,the following implementation pathways are proposed:utilizing principles as the guide to form cultural productivity,employing talent as the impetus to establish knowledge productivity,placing technology at the core to foster integration productivity,recognizing data as key to developing innovative productivity,and using cooperation as the link to create collaborative productivity within smart hospitals.

In the context of comprehensively advancing the Healthy China initiative,the high-quality development of public hospitals must be guided by the core principle of"people's health".It provides a systematic analysis of the historical evolution of developmental paradigms in Chinese public hospitals.By integrating the current policy requirements for their high-quality development,it proposes key pathways including the innovation of development concepts,the reconstruction of hospital connotations,the extension of service management,the optimization of the system structure,and the empowerment of digital and intelligent technologies.Through empirical case studies that demonstrate the viability of these pathways,it aims to provide theoretical support and practical reference for the high-quality development of public hospitals centered on people's health.

Objective To investigate the induction factors of hypotension during cesarean section for perilous placenta previa under combined spinal-epidural anesthesia (CSEA) and to construct a nomogram prediction model. Methods A total of 130 parturients who underwent cesarean section for perilous placenta previa under CSEA from January 2020 to December 2023 in Yulin Maternity and Child Healthcare Hospital were selected as study subjects. A self-designed general information questionnaire was used to investigate the basic information and the occurrence of hypotension of the subjects. According to the occurrence of intraoperative hypotension, the patients were divided into hypotension group (47 cases) and non-hypotension group (83 cases). Univariate analysis was performed on the general information of the two groups, and multivariate Logistic regression analysis was used to explore the induction factors of intraoperative hypotension. Results Univariate analysis showed that there were statistically significant differences in body mass index, anesthesia level, presence of multiple pregnancy, preoperative systolic blood pressure, operative time, and the occurrence of Bezold-Jarisch reflex between the two groups (P < 0.05). Multivariate Logistic regression analysis revealed that body mass index≥ 24 kg/m², anesthesia level was in the eighth thoracic vertebra(T8) or above, multiple pregnancy, preoperative systolic blood pressure < 90 mmHg, operative time >1.5 h, and the occurrence of Bezold-Jarisch reflex were independent risk factors for hypotension during cesarean section for perilous placenta previa under CSEA (P < 0.05). A regression equation for the induction factors of hypotension during cesarean section for perilous placenta previa under CSEA was constructed: Logit(P)=-23.211+1.079×(body mass index ≥ 24 kg/m²)+1.101×anesthesia level (≥T8)+3.193×multiple pregnancy+2.214×preoperative systolic blood pressure (< 90 mmHg)+4.606×operative time (>1.5 h)+2.011×occurrence of Bezold-Jarisch reflex. The nomogram showed high discrimination and accuracy for patients with preoperative systolic blood pressure < 90 mmHg. After 1, 000 times of Bootstrap resampling for the nomogram model, a calibration curve was obtained, and the consistency index was calculated as 0.850, indicating good calibration of the nomogram model. The receiver operating characteristic (ROC) curve was plotted, with an area under the curve of 0.896 and 95% confidence interval of 0.802 to 0.956, suggesting good predictive performance. Conclusion Body mass index ≥24 kg/m², anesthesia level ≥ T8, multiple pregnancy, preoperative systolic blood pressure < 90 mmHg, operative time >1.5 h, and the occurrence of Bezold-Jarisch reflex are induction factors for hypotension during cesarean section for perilous placenta previa under CSEA.

Botulinum toxin type A (BTX-A) is widely used in clinical practice due to its precise efficacy, high safety and low invasiveness. BTX-A injections may cause some common complications, such as unnatural expression, brow deformity, ptosis, diplopia, and, rarely, allergic reactions, dysphagia, and dyspnea. There are reports in the literature that visual loss can also occur after injection, and although there are very few relevant reports, this should also attract sufficient attention from clinicians. To this end, the authors reviewed the relevant literature in recent years and reviewed the clinical manifestations, pathogenesis and treatment method of vision loss caused by BTX-A injection.

Botulinum toxin type A (BTX-A) is widely used in clinical practice due to its precise efficacy, high safety and low invasiveness. BTX-A injections may cause some common complications, such as unnatural expression, brow deformity, ptosis, diplopia, and rare allergic reactions, dysphagia, and dyspnea. There are reports in the literature that visual loss can also occur after injection, and although there are very few relevant reports, clinicians should pay enough attention on it. To this end, the authors reviewed the relevant literature in recent years and reviewed the clinical manifestations, pathogenesis and treatment method of vision loss caused by BTX-A injection.

ObjectiveTo tentatively understand the status of radioactive contamination in nuclear medicine personnel. MethodsA total of 34 radiation staff engaged in nuclear medicine diagnosis and treatment were selected from two hospitals in Shanghai as the survey subjects.Among the 34 medical staff， 8 were nuclear medicine doctors， 14 were nuclear medicine technicians and 12 were nuclear medicine nurses. After surface contamination monitoring was first carried out to confirm that they had no surface radioactivity contamination， whole body scanning was performed with a whole body counter to determine whether they were internally contaminated with artificial radionuclides. ResultsThe α surface contamination was not detected in the nuclear medical staff. The β surface contamination of the nuclear medicine doctors， technicians and nurses was （13.8±0.8）， （14.1±0.8） and （14.0±0.7） times per second， respectively. There were 2， 2， and 4 nuclear medicine doctors who were contaminated with ¹⁸F， ^99mTc and ¹³¹I， 3， 5， and 2 nuclear medicine technicians who were contaminated with ¹⁸F， ^99mTc and ¹³¹I， and 6， 8， and 5 nuclear medicine nurses who were contaminated with ¹⁸F， ^99mTc and ¹³¹I， respectively. The ¹⁸F activity of nuclear medicine technicians was 1 997‒9 401 Bq， and the ^99mTc activity of nuclear medicine technicians and nurses was 3 699‒18 692 and 652‒388 22 Bq， respectively. One nuclear medicine nurse had a ^99mTc activity of 35 389 Bq. According to the preliminary estimation of ¹³¹I internal irradiation dose， the maximum committed effective dose of nuclear medicine doctors， technicians and nurses could reach 0.370， 0.018 and 0.584 mSv， respectively. ConclusionThe nuclear medicine staff are exposed to radioactive contamination， and it is important to monitor and evaluate their internal radiation doses.

Botulinum toxin type A (BTX-A) is widely used in clinical practice due to its precise efficacy, high safety and low invasiveness. BTX-A injections may cause some common complications, such as unnatural expression, brow deformity, ptosis, diplopia, and, rarely, allergic reactions, dysphagia, and dyspnea. There are reports in the literature that visual loss can also occur after injection, and although there are very few relevant reports, this should also attract sufficient attention from clinicians. To this end, the authors reviewed the relevant literature in recent years and reviewed the clinical manifestations, pathogenesis and treatment method of vision loss caused by BTX-A injection.

Botulinum toxin type A (BTX-A) is widely used in clinical practice due to its precise efficacy, high safety and low invasiveness. BTX-A injections may cause some common complications, such as unnatural expression, brow deformity, ptosis, diplopia, and rare allergic reactions, dysphagia, and dyspnea. There are reports in the literature that visual loss can also occur after injection, and although there are very few relevant reports, clinicians should pay enough attention on it. To this end, the authors reviewed the relevant literature in recent years and reviewed the clinical manifestations, pathogenesis and treatment method of vision loss caused by BTX-A injection.